Skip to main content
SpringerLink
Log in

Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Atrial fibrillation is the most common arrhythmia and is especially clinically important in patients with heart failure. Prolonged atrial fibrillation with high ventricular rate response may lead to development or worsening of left ventricular function. If adequate heart rate control cannot be obtained medically, often patients will undergo pacemaker implant and catheter ablation of the atrioventricular junction. This intervention can have profound effects on the course of heart failure. This article reviews the technique, complications, outcome data, and alternatives to this management strategy. The potential role of this therapeutic modality in those hospitalized with acute heart failure syndromes is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Deedwania PC, Singh BN, Ellenbogen K, Fisher S, Fletcher R (1998) Singh SN: Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators. Circulation 98:2574–2579

    PubMed  CAS  Google Scholar 

  2. Seiler J, Lee JC, Roberts-Thomson KC, Stevenson WG (2009) Intracardiac echocardiography guided catheter ablation of incessant ventricular tachycardia from the posterior papillary muscle causing tachycardia–mediated cardiomyopathy. Heart Rhythm 6:389–392

    Article  PubMed  Google Scholar 

  3. Fujino T, Yamashita T, Suzuki S, Sugiyma H, Sagara K, Sawada H, Aizawa T, Igarashi M, Yamazaki J (2007) Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy. Circulation Journal 71:936–940

    Article  PubMed  Google Scholar 

  4. Gonzalez R, Scheinman M, Margaretten W, Rubinstein M (1981) Closed-chest electrode-catheter technique for his bundle ablation in dogs. Am J Physiol 241:H283–H287

    PubMed  CAS  Google Scholar 

  5. Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton A, Critelli G (1982) Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 306:194–200

    Article  PubMed  CAS  Google Scholar 

  6. Scheinman MM, Morady F, Hess DS, Gonzalez R (1982) Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. JAMA 248:851–855

    Article  PubMed  CAS  Google Scholar 

  7. Scheinman M (1983) Transvenous AV junctional ablation. Am Heart J 106:607–608

    Article  PubMed  CAS  Google Scholar 

  8. Gonzalez R, Scheinman M, Bharati S, Lev M (1983) Closed chest permanent atrioventricular block in dogs. Am Heart J 105:461–470

    Article  PubMed  CAS  Google Scholar 

  9. Huang SK, Bharati S, Lev M, Marcus FI (1987) Electrophysiologic and histologic observations of chronic atrioventricular block induced by closed-chest catheter desiccation with radiofrequency energy. Pacing Clin Electrophysiol 10:805–816

    Article  PubMed  CAS  Google Scholar 

  10. Huang SK, Bharati S, Graham AR, Lev M, Marcus FI, Odell RC (1987) Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy—a new method of catheter ablation. J Am Coll Cardiol 9:349–358

    Article  PubMed  CAS  Google Scholar 

  11. Yeung-Lai-Wah JA, Alison JF, Lonergan L, Mohama R, Leather R, Kerr CR (1991) High success rate of atrioventricular node ablation with radiofrequency energy. J Am Coll Cardiol 18:1753–1758

    Article  PubMed  CAS  Google Scholar 

  12. Sousa J, el-Atassi R, Rosenheck S, Calkins H, Langberg J, Morady F (1991) Radiofrequency catheter ablation of the atrioventricular junction from the left ventricle. Circulation 84:567–571

    PubMed  CAS  Google Scholar 

  13. Issa ZF (2007) An approach to ablate and pace: AV junction ablation and pacemaker implantation performed concurrently from the same venous access site. Pacing Clin Electrophysiol 30:1116–1120

    Article  PubMed  Google Scholar 

  14. Kay GN, Ellenbogen KA, Giudici M, Redfield MM, Jenkins LS, Mianulli M, Wilkoff B (1998) The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT investigators. J Interv Card Electrophysiol 2:121–135

    Article  PubMed  CAS  Google Scholar 

  15. Proclemer A, Facchin D, Pagnutti C, Fioretti P, De Michele C (2000) Safety of pacemaker implantation prior to radiofrequency ablation of atrioventricular junction in a single session procedure. Pacing Clin Electrophysiol 23:998–1002

    Article  PubMed  CAS  Google Scholar 

  16. Khasnis A, Jongnarangsin K, Abela G, Veerareddy S, Reddy V, Thakur R (2005) Tachycardia-induced cardiomyopathy: a review of literature. Pacing Clin Electrophysiol 28:710–721

    Article  PubMed  Google Scholar 

  17. Shinbane JS, Wood MA, Jensen DN, Ellenbogen KA, Fitzpatrick AP, Scheinman MM (1997) Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies. J Am Coll Cardiol 29:709–715

    Article  PubMed  CAS  Google Scholar 

  18. Lemery R, Brugada P, Cheriex E, Wellens HJ (1987) Reversibility of tachycardia-induced left ventricular dysfunction after closed-chest catheter ablation of the atrioventricular junction for intractable atrial fibrillation. Am J Cardiol 60:1406–1408

    Article  PubMed  CAS  Google Scholar 

  19. Peters KG, Kienzle MG (1988) Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm. Am J Med 85:242–244

    Article  PubMed  CAS  Google Scholar 

  20. Grogan M, Smith HC, Gersh BJ, Wood DL (1992) Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy. Am J Cardiol 69:1570–1573

    Article  PubMed  CAS  Google Scholar 

  21. Gillette PC, Smith RT, Garson A Jr, Mullins CE, Gutgesell HP, Goh TH, Cooley DA, McNamara DG (1985) Chronic supraventricular tachycardia. A curable cause of congestive cardiomyopathy. JAMA 253:391–392

    Article  PubMed  CAS  Google Scholar 

  22. Cruz FE, Cheriex EC, Smeets JL, Atie J, Peres AK, Penn OC, Brugada P, Wellens HJ (1990) Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia. J Am Coll Cardiol 16:739–744

    Article  PubMed  CAS  Google Scholar 

  23. Fyfe DA, Gillette PC, Crawford FA Jr, Kline CH (1987) Resolution of dilated cardiomyopathy after surgical ablation of ventricular tachycardia in a child. J Am Coll Cardiol 9:231–234

    Article  PubMed  CAS  Google Scholar 

  24. Fujino T, Yamashita T, Suzuki S, Sugiyma H, Sagara K, Sawada H, Aizawa T, Igarashi M, Yamazaki J (2007) Characteristics of congestive heart failure accompanied by atrial fibrillation with special reference to tachycardia-induced cardiomyopathy. Circ J 71:936–940

    Article  PubMed  Google Scholar 

  25. Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek N (1987) Experimental congestive heart failure produced by rapid ventricular pacing in the dog: cardiac effects. Circulation 75:857–867

    Article  PubMed  CAS  Google Scholar 

  26. Moe GW, Grima EA, Howard RJ, Seth R, Armstrong PW (1994) Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure. Cardiovasc Res 28:66–71

    Article  PubMed  CAS  Google Scholar 

  27. Tomita M, Spinale FG, Crawford FA, Zile MR (1991) Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function. Circulation 83:635–644

    PubMed  CAS  Google Scholar 

  28. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J-Y, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc J-J, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 8:651–745

    Google Scholar 

  29. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD (2002) A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347:1825–1833

    Article  PubMed  CAS  Google Scholar 

  30. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM (2002) A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347:1834–1840

    Article  PubMed  Google Scholar 

  31. Van Gelder IC, Wyse DG, Chandler ML, Cooper HA, Olshansky B, Hagens VE, Crijns HJGM (2006) Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. Europace 8:935–942

    Article  PubMed  Google Scholar 

  32. Van Gelder IC, Groenveld HF, Crijns HJGM, Tuininga YS, Tijssen JGP, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP (2010) the RIII: Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 362:1363–1373

    Article  PubMed  Google Scholar 

  33. Bharati S, Scheinmann MM, Morady F, Hess DS, Lev M (1985) Sudden death after catheter-induced atrioventricular junctional ablation. Chest 88:883–889

    Article  PubMed  CAS  Google Scholar 

  34. Lemery R, Brugada P, Havenith M, Barbour D, Roberts WC, Wellens HJ (1988) Sudden death in hemochromatosis after closed-chest catheter ablation of the atrioventricular junction. Am J Cardiol 61:941–943

    Article  PubMed  CAS  Google Scholar 

  35. Olgin JE, Scheinman MM (1993) Comparison of high energy direct current and radiofrequency catheter ablation of the atrioventricular junction. J Am Coll Cardiol 21:557–564

    Article  PubMed  CAS  Google Scholar 

  36. Darpo B, Walfridsson H, Aunes M, Bergfeldt L, Edvardsson N, Linde C, Lurje L, van der Linden M, Rosenqvist M (1997) Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation. Am J Cardiol 80:1174–1177

    Article  PubMed  CAS  Google Scholar 

  37. Ozcan C, Jahangir A, Friedman PA, Hayes DL, Munger TM, Rea RF, Lloyd MA, Packer DL, Hodge DO, Gersh BJ, Hammill SC, Shen WK (2002) Sudden death after radiofrequency ablation of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 40:105–110

    Article  PubMed  Google Scholar 

  38. Evans GT Jr, Scheinman MM, Bardy G, Borggrefe M, Brugada P, Fisher J, Fontaine G, Huang SK, Huang WH, Josephson M et al (1991) Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter study. Circulation 84:1924–1937

    PubMed  Google Scholar 

  39. Ozcan C, Jahangir A, Friedman PA, Patel PJ, Munger TM, Rea RF, Lloyd MA, Packer DL, Hodge DO, Hayes DL, Gersh BJ, Hammill SC, Shen W-K (2001) Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med 344:1043–1051

    Article  PubMed  CAS  Google Scholar 

  40. Brignole M, Gianfranchi L, Menozzi C, Bottoni N, Bollini R, Lolli G, Oddone D, Gaggioli G (1994) Influence of atrioventricular junction radiofrequency ablation in patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 74:242–246

    Article  PubMed  CAS  Google Scholar 

  41. Betts TR (2008) Atrioventricular junction ablation and pacemaker implant for atrial fibrillation: still a valid treatment in appropriately selected patients. Europace 10:425–432

    Article  PubMed  Google Scholar 

  42. Brignole M, Menozzi C, Gianfranchi L, Musso G, Mureddu R, Bottoni N, Lolli G (1998) Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. Circulation 98:953–960

    PubMed  CAS  Google Scholar 

  43. Tan ES, Rienstra M, Wiesfeld ACP, Schoonderwoerd BA, Hobbel HHF, Van Gelder IC (2008) Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation. Europace 10:412–418

    Article  PubMed  Google Scholar 

  44. Twidale N, Manda V, Nave K, Seal A (1998) Predictors of outcome after radiofrequency catheter ablation of the atrioventricular node for atrial fibrillation and congestive heart failure. Am Heart J 136:647–657

    Article  PubMed  CAS  Google Scholar 

  45. Tops LF, Schalij MJ, Bax JJ (2009) The effects of right ventricular apical pacing on ventricular function and dyssynchrony: implications for therapy. J Am Coll Cardiol 54:764–776

    Article  PubMed  Google Scholar 

  46. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937

    Article  PubMed  Google Scholar 

  47. The David Trial Investigators (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the dual chamber and VVI implantable defibrillator (DAVID) trial. JAMA 288:3115–3123

    Article  Google Scholar 

  48. Sweeney MO, Prinzen FW (2006) A new paradigm for physiologic ventricular pacing. J Am Coll Cardiol 47:282–288

    Article  PubMed  Google Scholar 

  49. Leclercq C, Walker S, Linde C, Clementy J, Marshall AJ, Ritter P, Djiane P, Mabo P, Levy T, Gadler F, Bailleul C, Daubert JC (2002) Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 23:1780–1787

    Article  PubMed  CAS  Google Scholar 

  50. Leon AR, Greenberg JM, Kanuru N, Baker CM, Mera FV, Smith AL, Langberg JJ, DeLurgio DB (2002) Cardiac resynchronization in patients with congestive heart failure and chronic atrial fibrillation: effect of upgrading to biventricular pacing after chronic right ventricular pacing. J Am Coll Cardiol 39:1258–1263

    Article  PubMed  Google Scholar 

  51. Rahul ND, Emile GD, Christopher F, Kyong T, Aurelio D, Mohamed HH, Luis AP (2005) Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (The PAVE Study). J Cardiovasc Electrophysiol 16:1160–1165

    Article  Google Scholar 

  52. Orlov MV, Gardin JM, Slawsky M, Bess RL, Cohen G, Bailey W, Plumb V, Flathmann H, Metz KD (2010) Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J 159:264–270

    Article  PubMed  Google Scholar 

  53. Mohamed HH, Roger AF, Edward MG, John PD, Kenneth AE, Richard LP (2006) Atrioventricular junction ablation followed by resynchronization therapy in patients with congestive heart failure and atrial fibrillation (AVERT-AF) study design. Pacing Clin Electrophysiol 29:1081–1088

    Article  Google Scholar 

  54. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J-Y, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the american college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European heart rhythm association and the heart rhythm society. J Am Coll Cardiol 48:e149–e246

    Google Scholar 

  55. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW (2009) 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American college of cardiology foundation/American heart association task force on practice guidelines developed in collaboration with the international society for heart and lung transplantation. J Am Coll Cardiol 53:e1–e90

    Google Scholar 

  56. Tolosana JM, Hernandez Madrid A, Brugada J, Sitges M, Garcia Bolao I, Fernandez Lozano I, Martinez Ferrer J, Quesada A, Macias A, Marin W, Escudier JM, Gomez AA, Gimenez Alcala M, Tamborero D, Berruezo A, Mont L (2008) Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (results of the Spanish atrial fibrillation and resynchronization [SPARE] study). Am J Cardiol 102:444–449

    Article  PubMed  Google Scholar 

  57. Gasparini M, Auricchio A, Regoli F, Fantoni C, Kawabata M, Galimberti P, Pini D, Ceriotti C, Gronda E, Klersy C, Fratini S, Klein HH (2006) Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol 48:734–743

    Article  PubMed  Google Scholar 

  58. Gasparini M, Auricchio A, Metra M, Regoli FO, Fantoni C, Lamp B, Curnis A, Vogt J, Klersy C (2008) Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J 29:1644–1652

    Article  PubMed  Google Scholar 

  59. Torp-Pedersen C, Moller M, Bloch-Thomsen PE, Kober L, Sandoe E, Egstrup K, Agner E, Carlsen J, Videbak J, Marchant B, Camm AJ, The Danish Investigations of A, Mortality on Dofetilide Study G (1999) Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med 341:857–865

    Google Scholar 

  60. Stulak JM, Dearani JA, Daly RC, Zehr KJ, Sundt TM III, Schaff HV (2006) Left ventricular dysfunction in atrial fibrillation: restoration of sinus rhythm by the cox-maze procedure significantly improves systolic function and functional status. Ann Thorac Surg 82:494–501

    Article  PubMed  Google Scholar 

  61. Khargi K, Hutten BA, Lemke B, Deneke T (2005) Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg 27:258–265

    Article  PubMed  Google Scholar 

  62. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666

    Article  PubMed  CAS  Google Scholar 

  63. Chen MS, Marrouche NF, Khaykin Y, Gillinov AM, Wazni O, Martin DO, Rossillo A, Verma A, Cummings J, Erciyes D, Saad E, Bhargava M, Bash D, Schweikert R, Burkhardt D, Williams-Andrews M, Perez-Lugones A, Abdul-Karim A, Saliba W, Natale A (2004) Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 43:1004–1009

    Article  PubMed  Google Scholar 

  64. Claudio T, Massimo M, Giovanni R, Andrea A, Lucia De L, Augusto P, Rafael Lopes F, Edo P, Francesco L, Vito P, Irma B (2006) Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol 29:962–970

    Article  Google Scholar 

  65. Hsu L-F, Jais P, Sanders P, Garrigue S, Hocini M, Sacher F, Takahashi Y, Rotter M, Pasquie J-L, Scavee C, Bordachar P, Clementy J, Haissaguerre M (2004) Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 351:2373–2383

    Article  PubMed  CAS  Google Scholar 

  66. Philip JG, William HS, Edward PG, David LIN, Sanjay D, Erica Zado P-C, David C, Francis EM (2007) Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol 18:9–14

    Article  Google Scholar 

  67. Sharma AD, Rizo-Patron C, Hallstrom AP, O’Neill GP, Rothbart S, Martins JB, Roelke M, Steinberg JS, Greene HL, Investigators D (2005) Percent right ventricular pacing predicts outcomes in the DAVID trial. Heart Rhythm 2:830–834

    Article  PubMed  Google Scholar 

  68. Wilkoff BL, Dual C, investigators VVIIDt (2003) The dual chamber and VVI implantable defibrillator (DAVID) trial: rationale, design, results, clinical implications and lessons for future trials. Cardiac Electrophysiol Rev 7:468–472

    Article  Google Scholar 

  69. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, Kutalek SP, Sharma A (2002) Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288:3115–3123

    Article  PubMed  Google Scholar 

  70. Jazayeri MR, Sra JS, Deshpande SS, Blanck Z, Dhala AA, Krum DP, Avitall B, Akhtar M (1993) Electrophysiologic spectrum of atrioventricular nodal behavior in patients with atrioventricular nodal reentrant tachycardia undergoing selective fast or slow pathway ablation. J Cardiovasc Electrophysiol 4:99–111

    Article  PubMed  CAS  Google Scholar 

  71. Morady F, Hasse C, Strickberger SA, Man KC, Daoud E, Bogun F, Goyal R, Harvey M, Knight BP, Weiss R, Bahu M (1997) Long-term follow-up after radiofrequency modification of the atrioventricular node in patients with atrial fibrillation. J Am Coll Cardiol 29:113–121

    Article  PubMed  CAS  Google Scholar 

  72. Carbucicchio C, Tondo C, Fassini G, Riva S, Agostoni P, Galli C, Della Bella P (1999) Modulation of the atrioventricular node conduction to achieve rate control in patients with atrial fibrillation: long-term results. Pacing Clin Electrophysiol 22:442–452

    Article  PubMed  CAS  Google Scholar 

  73. Twidale N, McDonald T, Nave K, Seal A (1998) Comparison of the effects of AV nodal ablation versus av nodal modification in patients with congestive heart failure and uncontrolled atrial fibrillation. Pacing Clin Electrophysiol 21:641–651

    Article  PubMed  CAS  Google Scholar 

  74. Lee SH, Chen SA, Tai CT, Chiang CE, Wen ZC, Cheng JJ, Ding YA, Chang MS (1998) Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation. J Am Coll Cardiol 31:637–644

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Cardiovascular Medicine, Froedtert East Clinics, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI, 53226, USA

    Jason C. Rubenstein & James A. Roth

Authors
  1. Jason C. Rubenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James A. Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jason C. Rubenstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubenstein, J.C., Roth, J.A. Atrioventricular junction ablation and pacemaker implantation for heart failure associated with atrial fibrillation: potential issues and therapies in the setting of acute heart failure syndrome. Heart Fail Rev 16, 457–465 (2011). https://doi.org/10.1007/s10741-011-9238-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10741-011-9238-2

Keywords

Search

Navigation